Cefepime versus cefpirome: The importance of creatinine clearance

Anesthesia and Analgesia

Volumn 97, Issue 4, 2003, Pages 1149-1154

  Lipman, Jeffrey ^a   Wallis, Steven C ^b   Boots, Robert J ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFPIROME; CEPHALOSPORIN DERIVATIVE;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; HUMAN; INTENSIVE CARE; KIDNEY DYSFUNCTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0141458039     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000077077.54084.B0     Document Type: Article

References (31)

1. Barradell LB, Bryson HM. Cefepime: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;47:471-505.
2. Wiseman LR, Lamb HM. Cefpirome: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs 1997;54:117-40.
3. Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatr 1986;108:835-40.
4. Fantin B, Farinotti R, Thabaut A, Carbon C. Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. J Antimicrob Chemother 1994;33:563-9.
5. Mouton JW, den Hollander JG. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 1994;38:931-6.
6. Davies J, Wendon J, Wyncoll D, Wade J. Antibiotic infusions reduce the incidence of resistant organisms in liver intensive care [abstract]. Intensive Care Med 2000;26:s269.
7. Lipman J, Wallis SC, Rickard C. Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing. Antimicrob Agents Chemother 1999;43:2559-61.
8. Turnidge JD. The pharmacodynamics of beta-lactams. Clin Infect Dis 1998;27:10-22.
9. Benko AS, Cappelletty DM, Kruse JA, Rybak MJ. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrob Agents Chemother 1996;40:691-5.
10. Lipman J, Crewe Brown HH, Saunders GL, Gous AG. Subtleties of antibiotic dosages: do doses and intervals make a difference in the critically ill? S Afr J Surg 1996;34:160-2.
11. Lipman J, Wallis SC, Rickard CM, Fraenkel D. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modeling calls for more frequent dosing. Intensive Care Med 2001;27:363-70.
12. Crokaert F. Pharmacodynamics, a tool for a better use of antibiotics. Intensive Care Med 2001;27:340-3.
13. Hanes SD, Wood GC, Herring V, et al. Intermittent and continuous ceftazidime infusion for critically ill trauma patients. Am J Surg 2000;179:436-40.
14. Burgess DS, Summers KK, Hardin TC. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion. Clin Ther 1999;21:1882-9.
15. Egerer G, Goldschmidt H, Salwender H, et al. Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation. Int J Antimicrob Agents 2000;15:119-23.
16. Angus BJ, Smith MD, Suputtamongkol Y, et al. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis. Br J Clin Pharmacol 2000;49:445-52.
17. Frame BC, Facca BF, Nicolau DP, Triesenberg SN. Population pharmacokinetics of continuous infusion ceftazidime. Clin Pharmacokinet 1999;37:343-50.
18. Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M. Rapid evaluation of creatinine clearance. Lancet 1971;1:1133-4.
19. Wells M, Lipman J. Measurements of glomerular filtration in the intensive care unit are only a rough guide to renal function. S Afr J Surg 1997;35:20-3.
20. Snider RD, Kruse JA, Bander JJ, Dunn GH. Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit. Pharmacotherapy 1995;15:747-53.
21. Brown R, Babcock R, Talbert J, et al. Renal function in critically ill postoperative patients: sequential assessment of creatinine osmolar and free water clearance. Crit Care Med 1980;8:68-72.
22. Grotsch H, Hajdu P. Interference by the new antibiotic cefpirome and other cephalosporins in clinical laboratory tests, with special regard to the "Jaffe" reaction. J Clin Chem Clin Biochem 1987;25:49-52.
23. Lipman J, Gomersall C, Gin T, et al. Continuous infusion ceftazidime in intensive care: a randomised controlled trial. J Antimicrob Chemother 1999;43:309-11.
24. Young RJ, Lipman J, Gin T, et al. Intermittent bolus dosing of ceftazidime in critically ill patients. J Antimicrob Chemother 1997;40:269-73.
25. Lugo G, Castaneda-Hernandez G. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Crit Care Med 1997;25:806-11.
26. Tang GJ, Tang JJ, Lin BS, et al. Factors affecting gentamicin pharmacokinetics in septic patients. Acta Anaesthesiol Scand 1999;43:726-30.
27. Pea F, Porreca L, Baraldo M, Furlanut M. High vancomycin dosage regimens required by intensive care unit patients co-treated with drugs to improve haemodynamics following cardiac surgical procedures. J Antimicrob Chemother 2000;45:329-35.
28. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-42.
29. Karchmer AW. Cephalosporins. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas & Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:274-91.
30. Odenholt I, Gustafsson I, Lowdin E, Cars O. Suboptimal antibiotic dosage as a risk factor for selection of penicillin -resistant Streptococcus pneumoniae: in vitro kinetic model. Antimicrob Agents Chemother 2003;47:518-23.
31. Sladen RN, Endo E, Harrison T. Two-hour versus 22-hour creatinine clearance in critically ill patients. Anesthesiology 1987;67:1013-6.